Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families

Breast Cancer Research and Treatment

Volumn 130, Issue 3, 2011, Pages 1057-1061

  Harvey, S L ^a   Milne, R L ^b   McLachlan, S A ^b,c   Friedlander, M L ^d   Birch, K E ^a   Weideman, P ^a   Goldgar, D ^e   Hopper, J L ^b   Phillips, K A ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; BRCA2; Breast cancer; Phenocopy; Risk

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FOLLOW UP; GENE MUTATION; GENE SEGREGATION; GENETIC RISK; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELATIVE; RISK ASSESSMENT; RISK REDUCTION; SELF REPORT; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MIDDLE AGED; MUTATION; PROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 82255162852     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1733-6     Document Type: Article

References (18)

1. CL Scott MA Jenkins MC Southey TA Davis JA Leary DF Easton KA Phillips JL Hopper 2003 Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics Hum Genet 112 5-6 542 551 12601471 1:CAS:528:DC%2BD3sXivVOgtrg%3D (Pubitemid 36869048)
2. AC Antoniou DF Easton 2006 Models of genetic susceptibility to breast cancer Oncogene 25 43 5898 5905 16998504 10.1038/sj.onc.1209879 1:CAS:528:DC%2BD28XhtVSgurjJ (Pubitemid 44453445)
3. SJ Dawson MA Price MA Jenkins JM McKinley PN Butow SA McLachlan GJ Lindeman P Weideman ML Friedlander JL Hopper KA Phillips 2008 Cancer risk management practices of noncarriers within BRCA1/2 mutation-positive families in the Kathleen Cuningham Foundation Consortium for research into familial breast cancer J Clin Oncol 26 2 225 232 18040054 10.1200/JCO.2007.11.0262 1:CAS:528:DC%2BD1cXitVWitL4%3D
4. A Smith A Moran MC Boyd M Bulman A Shenton L Smith R Iddenden ER Woodward F Lalloo ER Maher DG Evans 2007 Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening J Med Genet 44 1 10 15 17079251 10.1136/jmg.2006.043091 1:CAS:528:DC%2BD2sXhvVGisro%3D (Pubitemid 46142833)
5. TM Allweis M Sagi T Peretz 2005 Sporadic breast cancer among relatives of BRCA mutation carriers Genet Med 7 9 655 656 16301869 10.1097/01.gim. 0000187155.63849.85 (Pubitemid 41754510)
6. J Gronwald C Cybulski J Lubinski SA Narod 2007 Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling J Med Genet 44 4 e76 17400795 10.1136/jmg.2006.048462
7. D Goldgar V Venne T Conner S Buys 2007 BRCA phenocopies or ascertainment bias? J Med Genet 44 8 e86 17673440 author reply e88
8. E Rowan A Poll SA Narod 2007 A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers J Med Genet 44 8 e89 17673443 author reply e88
9. SM Domchek MM Gaudet JE Stopfer MH Fleischaut J Powers N Kauff K Offit KL Nathanson M Robson 2010 Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2 Breast Cancer Res Treat 119 2 409 414 19885732 10.1007/s10549-009-0611-y 1:CAS:528:DC%2BD1MXhsFyjsL7P
10. LA Korde CM Mueller JT Loud JP Struewing K Nichols MH Greene PL Mai 2011 No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families Breast Cancer Res Treat 125 1 169 173 20458532 10.1007/s10549-010-0923-y 1:CAS:528:DC%2BC3cXhsFWgtL%2FI
11. Kathleen Cuningham Consortium for Research into Familial Breast Cancer: kConFab. Online resource. http://www.kconfab.org
12. GJ Mann H Thorne RL Balleine PN Butow CL Clarke E Edkins GM Evans S Fereday E Haan M Gattas GG Giles J Goldblatt JL Hopper J Kirk JA Leary G Lindeman E Niedermayr KA Phillips S Picken GM Pupo C Saunders CL Scott AB Spurdle G Suthers K Tucker G Chenevix-Trench 2006 Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource Breast Cancer Res 8 1 R12 16507150 10.1186/bcr1377 (Pubitemid 44644827)
13. KA Phillips PN Butow AE Stewart JH Chang PC Weideman MA Price SA McLachlan GJ Lindeman MJ McKay ML Friedlander JL Hopper 2005 Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort Fam Cancer 4 2 105 113 15951960 10.1007/s10689-004-6129-x (Pubitemid 40897810)
14. AIHW (2010) In: Welfare AIoHa (ed) ACIM (Australian Cancer Incidence and Mortality) books. AIHW Australian Government, Canberra. http://www.aihw.gov.au/ acim-books/
15. PD Pharoah JM Lipscombe KL Redman NE Day DF Easton BA Ponder 2000 Familial predisposition to breast cancer in a British population: implications for prevention Eur J Cancer 36 6 773 779 10762751 10.1016/S0959-8049(00)00023-X 1:STN:280:DC%2BD3c3islKgtw%3D%3D (Pubitemid 30179750)
16. AD Bakos SP Hutson JT Loud JA Peters RM Giusti MH Greene 2008 BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience Health Expect 11 3 220 231 18816319 10.1111/j.1369-7625.2008.00494.x
17. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R; SEARCH collaborators, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Schürmann P, Dörk T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock IW, MacPherson G, Reed MW, Couch FJ, Goode EL, Olson JE, Meijers-Heijboer H, van den Ouweland A, Uitterlinden A, Rivadeneira F, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Hopper JL, McCredie M, Southey M, Giles GG, Schroen C, Justenhoven C, Brauch H, Hamann U, Ko YD, Spurdle AB, Beesley J, Chen X, kConFab, AOCS Management Group, Mannermaa A, Kosma VM, Kataja V, Hartikainen J, Day NE, Cox DR, Ponder BA (2007) Genome-wide association study identifies multiple breast cancer susceptibility loci. Nature 447(7148):1087-1093
18. HA Katki MH Gail MH Greene 2007 Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families Lancet Oncol 8 12 1042 1043 18054868 10.1016/S1470-2045(07)70348-0 (Pubitemid 350182956)